Aralez pharmaceuticals inc. (ARLZ)
Income statement / TTM
Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Jun'15Mar'15
Revenues:
Product revenues, net

-

-

31,350

29,946

-

25,432

0

0

0

-

-

-

Other revenues

-

-

66,582

57,276

-

28,838

0

0

0

0

0

0

Total revenues, net

-

-

97,932

87,222

-

54,270

0

0

0

0

0

0

Product
Other
Revenues:
Revenues

0

-

-

-

0

-

-

-

-

-

-

-

Costs and expenses:
Cost of product revenues (exclusive of amortization shown separately below)

0

-

-

-

0

-

-

-

-

-

-

-

Cost of product revenues (exclusive of amortization shown separately below)

-

-

11,263

11,571

-

11,765

0

0

0

-

-

-

Selling, general and administrative

112,228

116,572

120,679

121,438

111,935

118,548

0

0

0

0

0

0

Research and development

2,267

2,324

2,467

3,768

4,514

8,832

0

0

0

0

0

0

Amortization of intangible assets

0

-

-

-

0

-

-

-

-

-

-

-

Amortization of intangible assets

-

-

32,485

26,232

-

12,591

0

0

0

-

-

-

Change in fair value of contingent consideration

36,367

35,725

0

0

0

-

-

-

-

-

-

-

Total costs and expenses

207,948

202,450

184,681

176,164

157,825

156,854

0

0

0

-

-

-

Total costs and expenses

-

-

-

-

-

-

-

-

-

0

0

0

Loss from operations

-89,889

-96,503

-86,749

-88,942

-85,643

-102,584

0

0

0

0

0

0

Interest expense

26,989

26,984

20,678

14,468

0

-

0

0

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

0

-

-

-

Other income (expense), net

59

682

1,933

1,676

1,297

5,683

0

0

0

0

0

0

Loss before income taxes

-116,819

-122,805

-109,745

-105,887

-96,833

-103,042

0

0

0

0

0

0

Income tax expense (benefit)

650

2,400

809

825

-166

-64

0

0

0

0

0

-

Net loss

-

-

-

-

-

-

-

-

0

0

0

0

Net loss

-117,469

-125,205

-100,037

-93,071

0

-

0

0

-

-

-

-

Basic net loss per common share (in dollars per share)

-0.29

-0.68

-0.37

-0.42

-0.42

-0.43

-0.32

-0.27

-0.65

-0.25

-0.50

0.00

Diluted net loss per common share (in dollars per share)

-0.29

-0.68

-0.37

-0.42

-0.42

-0.42

-0.32

-0.27

-0.73

-0.25

-0.50

0.00

Shares used in computing basic net loss per common share

67,025

66,919

66,837

66,110

65,690

65,579

65,229

64,360

52,156

32,732

32,436

32,259

Shares used in computing diluted net loss per common share

67,025

66,919

66,837

66,110

65,690

65,449

65,229

64,363

52,491

32,732

32,436

32,259